Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients. [electronic resource] by
- Schaich, M
- Kestel, L
- Pfirrmann, M
- Robel, K
- Illmer, T
- Kramer, M
- Dill, C
- Ehninger, G
- Schackert, G
- Krex, D
Producer: 20090319
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 20
Availability: No items available.
|
|
|
9.
|
|
|
|
10.
|
Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia. [electronic resource] by
- Pfirrmann, M
- Baccarani, M
- Saussele, S
- Guilhot, J
- Cervantes, F
- Ossenkoppele, G
- Hoffmann, V S
- Castagnetti, F
- Hasford, J
- Hehlmann, R
- Simonsson, B
Producer: 20160601
In:
Leukemia vol. 30
Availability: No items available.
|
|
|
11.
|
Prognosis and prognostic factors for patients with chronic myeloid leukemia: nontransplant therapy. [electronic resource] by
- Hasford, J
- Pfirrmann, M
- Hehlmann, R
- Baccarani, M
- Guilhot, F
- Mahon, F X
- Kluin-Nelemans, H C
- Ohnishi, K
- Thaler, J
- Steegmann, J L
Producer: 20031008
In:
Seminars in hematology vol. 40
Availability: No items available.
|
|
|
12.
|
Gender aspects in chronic myeloid leukemia: long-term results from randomized studies. [electronic resource] by
- Berger, U
- Maywald, O
- Pfirrmann, M
- Lahaye, T
- Hochhaus, A
- Reiter, A
- Hasford, J
- Heimpel, H
- Hossfeld, D K
- Kolb, H-J
- Löffler, H
- Pralle, H
- Queisser, W
- Hehlmann, R
Producer: 20050630
In:
Leukemia vol. 19
Availability: No items available.
|
|
|
13.
|
The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib. [electronic resource] by
- Hoffmann, V S
- Baccarani, M
- Lindoerfer, D
- Castagnetti, F
- Turkina, A
- Zaritsky, A
- Hellmann, A
- Prejzner, W
- Steegmann, J-L
- Mayer, J
- Indrak, K
- Colita, A
- Rosti, G
- Pfirrmann, M
Producer: 20131210
In:
Leukemia vol. 27
Availability: No items available.
|
|
|
14.
|
Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial. [electronic resource] by
- Stölzel, F
- Pfirrmann, M
- Aulitzky, W E
- Kaufmann, M
- Bodenstein, H
- Bornhäuser, M
- Röllig, C
- Kramer, M
- Mohr, B
- Oelschlägel, U
- Schmitz, N
- Soucek, S
- Thiede, C
- Ehninger, G
- Schaich, M
Producer: 20110513
In:
Leukemia vol. 25
Availability: No items available.
|
|
|
15.
|
Cytogenetic response to prior treatment with interferon-alpha is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia. [electronic resource] by
- Maywald, O
- Pfirrmann, M
- Berger, U
- Breitscheidel, L
- Gratwohl, A
- Kolb, H-J
- Beelen, D W
- Tobler, A
- Metzgeroth, G
- Gnad, S U
- Hochhaus, A
- Hasford, J
- Hehlmann, R
- Reiter, A
Producer: 20060425
In:
Leukemia vol. 20
Availability: No items available.
|
|
|
16.
|
Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial. [electronic resource] by
- Buesche, G
- Hehlmann, R
- Hecker, H
- Heimpel, H
- Heinze, B
- Schmeil, A
- Pfirrmann, M
- Gomez, G
- Tobler, A
- Herrmann, H
- Kappler, M
- Hasford, J
- Buhr, T
- Kreipe, H-H
- Georgii, A
Producer: 20040123
In:
Leukemia vol. 17
Availability: No items available.
|
|
|
17.
|
Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia. [electronic resource] by
- Buesche, G
- Freund, M
- Hehlmann, R
- Georgii, A
- Ganser, A
- Hecker, H
- Heimpel, H
- Fonatsch, C
- Heinze, B
- Pfirrmann, M
- Holgado, S
- Schmeil, A
- Tobler, A
- Hasford, J
- Buhr, T
- Kreipe, H-H
Producer: 20040916
In:
Leukemia vol. 18
Availability: No items available.
|
|
|
18.
|
Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alpha. [electronic resource] by
- Berger, U
- Engelich, G
- Maywald, O
- Pfirrmann, M
- Hochhaus, A
- Reiter, A
- Metzgeroth, G
- Gnad, U
- Hasford, J
- Heinze, B
- Heimpel, H
- Hossfeld, D K
- Kolb, H-J
- Löffler, H
- Pralle, H
- Queisser, W
- Hehlmann, R
Producer: 20031021
In:
Leukemia vol. 17
Availability: No items available.
|
|
|
19.
|
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis. [electronic resource] by
- Jawhar, M
- Schwaab, J
- Schnittger, S
- Meggendorfer, M
- Pfirrmann, M
- Sotlar, K
- Horny, H-P
- Metzgeroth, G
- Kluger, S
- Naumann, N
- Haferlach, C
- Haferlach, T
- Valent, P
- Hofmann, W-K
- Fabarius, A
- Cross, N C P
- Reiter, A
Producer: 20160601
In:
Leukemia vol. 30
Availability: No items available.
|
|
|
20.
|
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure. [electronic resource] by
- Hehlmann, R
- Hochhaus, A
- Kolb, H J
- Hasford, J
- Gratwohl, A
- Heimpel, H
- Siegert, W
- Finke, J
- Ehninger, G
- Holler, E
- Berger, U
- Pfirrmann, M
- Muth, A
- Zander, A
- Fauser, A A
- Heyll, A
- Nerl, C
- Hossfeld, D K
- Löffler, H
- Pralle, H
- Queisser, W
- Tobler, A
Producer: 19991230
In:
Blood vol. 94
Availability: No items available.
|